Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Stocktreeon Mar 01, 2023 3:17pm
151 Views
Post# 35313286

RE:Good to see...

RE:Good to see...
The BS continues. Given the pharaonic future revenues EDT is bound to earn, according to you and your fan club, a few salaries wouldn't make a difference if the company attracted real interest.

Oh, and the ICU workers comment is just... sooooo slimy and on brand with your dishonest approach.
This board, according to you, should not serve to diss on management for their complete failure to add value to the stock for their shareholders and to complete a trial at a normal pace. Posters should instead follow direct channels (to not hurt fellow SHs who want to day-trade their shares).

But for ICU workers (read doctors, because everybody knows it ain't the nursing staff who is taking decisions as to the enrollment of patients in a study or the time they should devote to it), it's fair game to assume they are responsible for the pace of the trial and to discuss the matter here. You should talk to their union, or to them directly, this is not the place to talk about people not doing their job. Especially as you have zero evidence that that would be the case.
<< Previous
Bullboard Posts
Next >>